TELA Bio to Announce First Quarter 2026 Financial Results
TELA Bio, Inc. is set to report its first quarter 2026 financial results on May 12, 2026. The company’s management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide corporate updates. TELA Bio focuses on innovative soft-tissue reconstruction solutions, aiming to optimize clinical outcomes by prioritizing patient anatomy preservation and restoration.
MALVERN, Pa., April 21, 2026 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report first quarter 2026 financial results on Tuesday, May 12, 2026. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.